Literature DB >> 3012872

The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serum.

B Banapour, J Sernatinger, J A Levy.   

Abstract

Unheated human serum does not lyse the AIDS-associated retrovirus (ARV), change the density of the virus, or suppress its ability to infect human peripheral mononuclear cells. The results indicate that ARV and the human oncovirus HTLV-I, unlike other animal retroviruses, are resistant to the effect of human serum. These two human viruses coming from different retrovirus subfamilies may be pathogenic because of this lack of sensitivity to human complement components.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3012872     DOI: 10.1016/0042-6822(86)90392-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

1.  Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha1-3)galactosylation.

Authors:  Y Takeuchi; S H Liong; P D Bieniasz; U Jäger; C D Porter; T Friedman; M O McClure; R A Weiss
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 2.  Development of retroviral vectors as safe, targeted gene delivery systems.

Authors:  W H Günzburg; B Salmons
Journal:  J Mol Med (Berl)       Date:  1996-04       Impact factor: 4.599

3.  Detection of HLA-DR associated with monocytotropic, primary, and plasma isolates of human immunodeficiency virus type 1.

Authors:  M N Saarloos; B L Sullivan; M A Czerniewski; K D Parameswar; G T Spear
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

Review 4.  Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.

Authors:  D C Montefiori
Journal:  Springer Semin Immunopathol       Date:  1997

Review 5.  Complement-related proteins in pathogenic organisms.

Authors:  Z Fishelson
Journal:  Springer Semin Immunopathol       Date:  1994

Review 6.  Enhancing role of complement in HIV infection.

Authors:  A Mouhoub; N Thieblemont; C Delibrias; E Fischer; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

7.  Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell.

Authors:  Y Takeuchi; F L Cosset; P J Lachmann; H Okada; R A Weiss; M K Collins
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59.

Authors:  J Schmitz; J P Zimmer; B Kluxen; S Aries; M Bögel; I Gigli; H Schmitz
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

9.  Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120.

Authors:  P L Nara; W G Robey; M A Gonda; S G Carter; P J Fischinger
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

10.  Foamy virus vectors.

Authors:  D W Russell; A D Miller
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.